专业监测看板

Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine

药物 / 成分：CoVLP formulation

登记的停止原因（原文）：Further development terminated

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

药物 / 成分：Candonilimab、Bevacizumab

登记的停止原因（原文）：Protocol adjustment

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)

药物 / 成分：Placebo、BIIB061、Interferon-beta1、Glatiramer acetate

登记的停止原因（原文）：Decision to discontinue BIIB061 program was based on lack of stronger preclinical effects of BIIB061 on remyelination relative to opicinumab, that showed limited clinical efficacy in phase 2 clinical studies. This was not related to safety concerns.

Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study

药物 / 成分：Blood sample、Blood sample

登记的停止原因（原文）：study not started

Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma

药物 / 成分：Tazemetostat、Ublituximab、Umbralisib

登记的停止原因（原文）：Feasibility

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

药物 / 成分：JK07、Matching Placebo

登记的停止原因（原文）：Sponsor decision

Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries

药物 / 成分：Ascorbic Acid 1000 mg、Placebo

登记的停止原因（原文）：Unfortunately, the economic crisis in Lebanon precluded utilization of available funding to recruit patients at the specified institution. No patients were recruited.

Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists

药物 / 成分：open-labeled inhaled corticosteroids (ICS); FORADIL® AEROLIZER®、foradil placebo、foradil

登记的停止原因（原文）：Drug supply sponsor sent outdated drug

Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia

药物 / 成分：DILTIAZEM TEVA 60 mg or placebo

登记的停止原因（原文）：the epidemiological situation has changed considerably.

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

药物 / 成分：paclitaxel albumin-stabilized nanoparticle formulation、gene expression analysis、laboratory biomarker analysis、pharmacological study